|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| C07D 473/34 | (2006.01) | ||
| A61K 31/5377 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61K 31/52 | (2006.01) |
| (11) | Number of the document | 2456444 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10800175.1 |
| Date of filing the European patent application | 2010-07-15 | |
| (97) | Date of publication of the European application | 2012-05-30 |
| (45) | Date of publication and mention of the grant of the patent | 2015-03-18 |
| (46) | Date of publication of the claims translation | 2015-08-25 |
| (86) | Number | PCT/US2010/002020 |
| Date | 2010-07-15 |
| (87) | Number | WO 2011/008302 |
| Date | 2011-01-20 |
| (30) | Number | Date | Country code |
| 503776 | 2009-07-15 | US |
| (72) |
REN, Pingda, US
LIU, Yi, US
WILSON, Troy, Edward, US
LI, Liansheng, US
CHAN, Katrina, US
ROMMEL, Christian, US
|
| (73) |
Intellikine, LLC,
10931 North Torrey Pines Road, Suite 103, La Jolla CA 92037,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Adenino dariniai, kaip P13K inhibitoriai |
| ADENINE DERIVATIVE AS PI3K INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 16 | 347.00 EUR |
| 2026-07-15 |